Latest On Yield10 Bioscience, Inc (YTEN):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-10 22:15 EST | News | Yield10 Bioscience GAAP EPS of -$0.76 misses by $0.13, revenue of $0.06M misses by $0.01M | N/A |  |
| 2023-05-10 22:15 EST | News | Yield10 Bioscience, Inc. (YTEN) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-10 22:15 EST | News | Yield10 Bioscience, Inc. 2023 Q1 - Results - Earnings Call Presentation | N/A | |
| 2023-05-09 20:01 EST | News | Yield10 Bioscience Q1 2023 Earnings Preview | N/A | |
| 2023-05-03 17:10 EST | News | Yield10 Bioscience prices $3M offering | N/A | |
About Yield10 Bioscience, Inc (YTEN):
Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing disruptive technologies for step-changing improvements in crop yield in the United States and Canada. The company, through its Trait Factory, is involved in developing high value seed traits for the agriculture and food industries. It also has an oilseed development center in Saskatchewan, Canada. Yield10 Bioscience, Inc. has research agreements with Bayer AG to develop traits in soybean; Forage Genetics International, LLC to develop traits in forage sorghum; J. R. Simplot Company to develop novel traits in potato; and GDM Seeds Inc. to evaluate yield traits in soybeans. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, In read more...c. was founded in 1992 and is headquartered in Woburn, Massachusetts.
General
- Name Yield10 Bioscience, Inc
- Symbol YTEN
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorBasic Materials
- IndustryAgricultural Inputs
- Last Split Factor1:40
- Last Split Date2020-01-16
- Fiscal Year EndDecember
- IPO Date2006-11-10
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.yield10bio.com
Valuation
- Price/Sales (Trailing 12 Mt.) 36.92
- Price/Book (Most Recent Quarter) 6.34
- Enterprise Value Revenue 73.18
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$2.12
- Next Year EPS Estimate -$1.83
- Next Quarter EPS Estimate -$0.64
- Operating Margin -1265%
- Return on Assets -45%
- Return on Equity -199%
- Revenue 744000
- Earnings Per Share -$0.80
- Revenue Per Share $0.44
- Gross Profit -4042000
- Quarterly Earnings Growth -8.9%
Highlights
- Market Capitalization 75.01 million
- EBITDA -8260000
- Analyst Target Price $25.33
- Book Value Per Share $4.02
Share Statistics
- Shares Outstanding 4.6 million
- Shares Float 2.47 million
- % Held by Insiders 3045%
- % Held by Institutions 8.37%
- Shares Short 61064
- Shares Short Prior Month 27727
- Short Ratio 0.25
- Short % of Float 1%
- Short % of Shares Outstanding 1%
Technicals
- Beta 1.36
- 52 Week High $23.49
- 52 Week Low $3.5
- 50 Day Moving Average 16
- 200 Day Moving Average 9.3
Dividends
- Dividend Date 2020-01-16
- ExDividend Date N/A
- Dividend Yield 0%
Yield10 Bioscience, Inc (YTEN) Dividend Calendar:
YTEN's last dividend payment was made to shareholders on January 16, 2020.
Yield10 Bioscience, Inc (YTEN) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Yield10 Bioscience, Inc (YTEN) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Yield10 Bioscience, Inc (YTEN) Chart:
Yield10 Bioscience, Inc (YTEN) News:
Below you will find a list of latest news for Yield10 Bioscience, Inc (YTEN) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Yield10 Bioscience, Inc (YTEN) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest YTEN Trades:
Yield10 Bioscience, Inc (YTEN) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-10-19 | 424B4 (Prospectus [Rule 424(b)(4)]) | |
| 2020-10-16 | EFFECT (Notice of Effectiveness) | |
| 2020-10-08 | S-1 (General form for registration of securities under the Securities Act of 1933) | |
| 2020-10-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-31 | SC 13G (Statement of acquisition of beneficial ownership by individuals) | |
| 2020-08-31 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-31 | SC 13D/A (General statement of acquisition of beneficial ownership) | |
| 2020-08-25 | 424B5 (Prospectus [Rule 424(b)(5)]) | |
| 2020-08-25 | 8-K (Current report) | |
| 2020-08-21 | 424B5 (Prospectus [Rule 424(b)(5)]) | |
| 2020-08-13 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-13 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-13 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-13 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-11 | 8-K (Current report) | |
| 2020-08-11 | 8-K (Current report) | |
| 2020-08-11 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-07-02 | 4 (Statement of changes in beneficial ownership of securities) | |
Yield10 Bioscience, Inc (YTEN) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Yield10 Bioscience, Inc (YTEN). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 3045%
Institutional Ownership: 837%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-08-26 | JACK W SCHULER | 10% Share Holder | Buy | 365,241.00 | 4.25 | 1,552,274.25 | 793,635.00 | |
| 2020-02-11 | CHARLES B HAASER | VP Fin & Chief Accting Officer | Buy | 4,000.00 | 4,055.00 | | ||
| 2020-02-11 | Kristi Snell | VP Research & CSO | Buy | 4,000.00 | 4,112.00 | | ||
| 2020-02-11 | LYNNE H BRUM | VP Planning & Comms | Buy | 4,000.00 | 4,186.00 | | ||
| 2020-02-11 | JACK W SCHULER | 10% Share Holder | Sell | 42,697.00 | 7.69 | 328,224.65 | 428,396.00 | |
| 2020-02-11 | Oliver P Peoples | Pres & CEO | Buy | 5,000.00 | 6,686.00 | | ||
| 2020-02-10 | JACK W SCHULER | 10% Share Holder | Sell | 28,256.00 | 7.90 | 223,180.02 | 471,093.00 | |
| 2020-02-10 | JACK W SCHULER | 10% Share Holder | Buy | 9,852.00 | 7.91 | 77,880.06 | 489,496.00 | |
| 2019-10-02 | Oliver P Peoples | Pres & CEO | Buy | 822.00 | 0.53 | 435.66 | 67,628.00 | |
| 2019-10-01 | Oliver P Peoples | Pres & CEO | Buy | 9,178.00 | 0.56 | 5,139.68 | 66,806.00 | |
| 2019-09-03 | Oliver P Peoples | Pres & CEO | Buy | 10,000.00 | 0.82 | 8,200.00 | 57,628.00 | |
| 2019-08-01 | Oliver P Peoples | Pres & CEO | Buy | 10,000.00 | 0.92 | 9,200.00 | 47,628.00 | |
| 2019-07-05 | Oliver P Peoples | Pres & CEO | Buy | 10,000.00 | 0.88 | 8,800.00 | 37,628.00 | |
| 2019-03-14 | JACK W SCHULER | 10% Share Holder | Buy | 552,427.00 | 1.21 | 668,491.91 | 3,822,908.00 | |
| 2017-12-19 | JACK W SCHULER | 10% Share Holder | Buy | 1,906,744.00 | 2.26 | 4,309,241.44 | 3,270,481.00 | |